| Literature DB >> 20396733 |
T A Voronina1, M V Belopol'skaya, I A Kheyfets, Yu L Dugina, S A Sergeeva, O I Epshtein.
Abstract
Course administration of ultralow doses of antibodies to S-100 protein restores cognitive functions and neurological status, improves emotional state, and reduces anxiety in animals with modeled Alzheimer disease based on cholinergic system deficiency caused by subchronic treatment with scopolamine.Entities:
Mesh:
Substances:
Year: 2009 PMID: 20396733 DOI: 10.1007/s10517-010-0757-y
Source DB: PubMed Journal: Bull Exp Biol Med ISSN: 0007-4888 Impact factor: 0.804